BLOG

How Does Aging Affect Stem Cells? A Guide Before Considering Treatment in Osaka

Published 2026.10.08 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Many people first become curious about regenerative medicine when they notice that recovery feels slower than it used to. Joints take longer to settle, injuries linger, and tissues seem less resilient. One idea often raised in this context is that the body’s stem cells change as we age. This article explains, in plain language, what is currently understood about aging and stem cells, and what that background means if you are thinking about adipose-derived stem cell therapy in Osaka, Japan.

The short answer

Research suggests that the number and the activity of stem cells in many tissues tend to decline with age. This is one of several factors discussed in relation to slower tissue repair. However, aging is complex, and a change in stem cells does not by itself explain every symptom a person may have. Nor does it guarantee that any treatment will reverse age-related changes. Whether a regenerative approach is appropriate for you can only be judged by a physician after a medical consultation.

What stem cells do in the body

The human body contains tens of trillions of cells, and many of them are replaced continuously. Stem cells are an important source of this renewal. They have two defining abilities: they can copy themselves, and they can develop into more specialized cell types. In this way they help maintain and repair tissues throughout life.

Mesenchymal stem cells, found in tissues such as fat and bone marrow, are a type of somatic stem cell. Besides their ability to develop into fat, bone, and cartilage cells, they have been reported in laboratory and clinical research to release anti-inflammatory substances and growth factors that may support the repair of damaged tissue. These are research findings, and results vary between studies and between individuals.

What is known about stem cells and aging

Studies in the scientific literature have described several age-related changes in stem cells. Reported observations include a reduction in the number of available cells, slower growth in culture, and changes in how the cells respond to their surroundings. Chronic low-grade inflammation, which tends to increase with age, is also discussed as something that may affect the environment in which stem cells work.

It is important to read this literature carefully. Many findings come from cell-culture or animal experiments, and studies that compare cells from younger and older donors do not always agree. Lifestyle, general health, and underlying conditions may also influence cell characteristics. For this reason, a single study should never be taken as proof that a particular treatment will or will not work for a particular person.

Why this matters for an autologous treatment

Adipose-derived stem cell therapy at Grand Green Osaka Umekita Clinic is an autologous approach. A very small amount of your own fat tissue is collected under local anesthesia, the mesenchymal stem cells it contains are cultured and expanded at a specialized facility, and the cells are then returned to your body by IV infusion. Because the cells come from you, factors such as your age and general health are naturally part of the discussion.

Fat tissue is considered to contain a comparatively abundant supply of mesenchymal stem cells, and collection is generally less burdensome than bone marrow collection. Still, the characteristics of cells vary from person to person, and the way cells grow during culture can differ. A physician can explain what is known, what is uncertain, and how your own situation may relate to these points. This is also why expectations should be set carefully: the treatment is not a way to reverse aging, and individual responses cannot be predicted in advance.

Questions worth asking at a consultation

Preparing a few questions can make a consultation more productive. Consider raising the following topics with the doctor:

Whether your current symptoms and medical history make this treatment a reasonable option to consider, or whether other approaches should come first.
How your age and general health may relate to the cells that would be collected and cultured.
The possible risks and side effects of fat collection, culture, and IV infusion, and how they are monitored.
How standard medical care for your condition fits alongside, or takes priority over, regenerative treatment.
The fees, the number of visits, and the overall time frame, so that you can plan travel if you live outside Osaka.

Regenerative treatment is not a substitute for standard care. If you are being treated for a medical condition, please continue to follow your own doctor’s guidance and share your plans with them.

Self-pay care and Japanese regulation

In Japan, adipose-derived stem cell therapy is offered as self-pay (non-insured) medical care, so national health insurance does not cover it. It is provided under a regenerative medicine provision plan in accordance with Japan’s Act on the Safety of Regenerative Medicine, which sets requirements for how such treatments are planned, reviewed, and reported. Fees, risks, side effects, and whether the treatment is suitable for you are confirmed with a doctor during consultation, and you are not obliged to proceed after hearing the explanation.

Grand Green Osaka Umekita Clinic is located in Umeda, Osaka, and provides information for international patients on a dedicated multilingual page. If you are considering a visit from overseas, reviewing that information and preparing your medical records in advance can help you use your consultation time well.

Summary

Stem cell numbers and activity are reported to change with age, which is one reason regenerative medicine attracts interest among people who feel their recovery has slowed. The evidence is still developing, individual differences are large, and no outcome can be promised. If you would like to learn whether adipose-derived stem cell therapy could be a reasonable option for you, the best next step is a medical consultation in which your history, expectations, risks, and costs can be reviewed carefully together.

Aging and Stem Cells: Key Points

Changes with ageReported in research
Own cells usedAutologous approach
Doctor consultationSuitability is assessed
Standard care firstNot a substitute

This diagram is a conceptual summary of the article content

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›